Search results
Results From The WOW.Com Content Network
The company expects to be profitable in 2025. [ 2 ] In July 2023 due to a disappointing sales ramp-up of the recently approved sleep drug daridorexant , coupled with disappointing trial results in both clazosentan and lucerestat , Idorsia announced layoffs of up to five hundred staff of its one thousand two hundred total employees, to reduce ...
Dec. 2—Pfizer Inc. is starting to roll out the pharmaceutical company's biggest round of layoffs since 2009, and its Groton laboratories are not immune. Of course, New York-based Pfizer these ...
The start of 2025 could herald a new return to office push. Corporate giants like Amazon and AT&T announced at the end of 2024 that they would bring their employees back into the office five days ...
Demonstrators gather outside of the Department of Health and Human Services in Washington, D.C. on February 14, 2025 to support federal workers and protest Elon Musk's Department of Government ...
In June 2023, Viatris was named to the Forbes Global 2000 list of the world's largest companies. [24] In October 2023, Viatris reached agreements to divest from almost all of its OTC business, its women’s healthcare business, and its India-based active pharmaceutical ingredients business for a total of about $3.6 billion. [25]
The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. [2] [3] With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas.
This story was first published on Jan. 17, 2025. It was updated on Jan. 20, 2025 to make clear that the 16,000 employees Starbucks has in corporate roles includes support staff, roasters ...
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, [3] with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.